Login
Register
Submit a Paper
Propose a Special lssue
Open Access
RETRACTION
Retraction notice to “High Blood miR-802 Is Associated With Poor Prognosis in HCC Patients by Regulating DNA Damage Response 1 (REDD 1)-Mediated Function of T Cells” [Oncology Research 27(9) (2019) 1025-1034]
* Department of Hepatobiliary Pancreatic Surgery, First Hospital of Jilin University, Changchun, P.R. China
† Department of Cardiology, China-Japan Union Hospital of Jilin University, Changchun, P.R. China
Oncology Research 2020, 28(7-8), 833-833. https://doi.org/10.3727/096504018X16233193839045
Download PDFAbstract
This article has no abstract.Cite This Article
APA Style
Jiang, C., Liu, X., Wang, M., Lv, G., Wang, G. (2020). Retraction notice to “high blood mir-802 is associated with poor prognosis in HCC patients by regulating DNA damage response 1 (REDD 1)-mediated function of T cells” [oncology research 27(9) (2019) 1025-1034]. Oncology Research, 28(7-8), 833-833. https://doi.org/10.3727/096504018X16233193839045
Vancouver Style
Jiang C, Liu X, Wang M, Lv G, Wang G. Retraction notice to “high blood mir-802 is associated with poor prognosis in HCC patients by regulating DNA damage response 1 (REDD 1)-mediated function of T cells” [oncology research 27(9) (2019) 1025-1034]. Oncol Res. 2020;28(7-8):833-833 https://doi.org/10.3727/096504018X16233193839045
IEEE Style
C. Jiang, X. Liu, M. Wang, G. Lv, and G. Wang "Retraction notice to “High Blood miR-802 Is Associated With Poor Prognosis in HCC Patients by Regulating DNA Damage Response 1 (REDD 1)-Mediated Function of T Cells” [Oncology Research 27(9) (2019) 1025-1034]," Oncol. Res., vol. 28, no. 7-8, pp. 833-833. 2020. https://doi.org/10.3727/096504018X16233193839045
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Downloads
Citation Tools
